Canopy Growth (CGC) Current Assets (2017 - 2026)
Canopy Growth (CGC) reported Current Assets of $386.1 million for Q1 2026, up 88.07% on a YoY basis from $205.3 million in Q1 2025, and up 309.82% sequentially from $94.2 million in Q4 2025.
Canopy Growth (CGC) Current Assets (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Current Assets data on file, last reported at $386.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 88.07% year-over-year to $386.1 million; the trailing twelve-month figure through Mar 2026 stood at $386.1 million (up 88.07% YoY), and the FY2026 full-year result was $386.1 million, up 88.07% from the prior year.
- Current Assets grew to $386.1 million in Q1 2026, from $94.2 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.4 billion in Q1 2022 to a low of $94.2 million in Q4 2025.
- A 5-year average of $522.4 million and a median of $323.9 million in 2025 frame the typical range for Current Assets.
- Across the five-year window, Current Assets tumbled 68.25% in 2023 and jumped 88.07% in 2026, its largest moves.
- Tracing CGC's Current Assets over 5 years: stood at $846.9 million in 2022, then sank by 65.54% to $291.8 million in 2023, then slumped by 64.34% to $104.1 million in 2024, then fell by 9.47% to $94.2 million in 2025, then soared by 309.82% to $386.1 million in 2026.
- Business Quant data shows CGC's Current Assets at $386.1 million in Q1 2026, $94.2 million in Q4 2025, and $323.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 386.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 386.09 Mn |
| Dec 31, 2025 | 94.21 Mn |
| Sep 30, 2025 | 323.95 Mn |
| Jun 30, 2025 | 218.94 Mn |
| Mar 31, 2025 | 205.29 Mn |
| Dec 31, 2024 | 104.06 Mn |
| Sep 30, 2024 | 287.11 Mn |
| Jun 30, 2024 | 261.60 Mn |
| Mar 31, 2024 | 275.46 Mn |
| Dec 31, 2023 | 291.82 Mn |
| Sep 30, 2023 | 368.26 Mn |
| Jun 30, 2023 | 657.52 Mn |
| Mar 31, 2023 | 796.84 Mn |
| Dec 31, 2022 | 846.93 Mn |
| Sep 30, 2022 | 1.16 Bn |
| Jun 30, 2022 | 1.24 Bn |
| Mar 31, 2022 | 1.36 Bn |
| Dec 31, 2021 | 1.58 Bn |
| Sep 30, 2021 | 1.99 Bn |
| Jun 30, 2021 | 2.18 Bn |